CBA official: Gillenwater, Harrell suspended for three months, Guangdong & Xinjiang deducted 6 points

6686 Sports News on November 6 Today, the CBA officially announced a letter of punishment for foreign aid Gillenwater and Harrell for violating drug prohibition regulations. The details are as follows.

"CBA clubs:

On October 13 and November 5, the Chinese Basketball Association announced notices on the treatment of agonist violations for basketball players Troy Akeem Gillenwater and Montrezl Dashay Harrell.

The notice stated that in accordance with the relevant provisions of the "Anti-Agonist Rules", athlete Troy Akeem was given Gillenwater was suspended for 3 months from October 13, 2025 to January 12, 2026. He was given a warning by Lin Zhida, the person in charge of medical and anti-agonist treatment at the Guangdong Hongyuan South China Tigers Club (hereinafter referred to as the "Guangdong Hongyuan Club"), a warning by the athlete management unit Guangdong Hongyuan Club, and a penalty of paying the cost of 20 agonist tests (RMB: 36,000 yuan); the penalty was given to the athlete Montrezl Dashay Harrell was suspended for 3 months from November 5, 2025 to February 4, 2026. He was given a warning by Wu Jie, the person in charge of medical and anti-agonist treatment at the Xinjiang Guanghui Flying Tigers Club (hereinafter referred to as the "Xinjiang Guanghui Club"), a warning by the athlete management unit Xinjiang Guanghui Club, and a penalty of paying the cost of 20 agonist tests (RMB: 36,000 yuan).

China Basketball Federation (Beijing). Beijing) Sports Co., Ltd. (referred to as "CBA Company") strictly implements the above-mentioned violation notice, and at the same time, in accordance with Article 22 of the "China Men's Basketball Professional League Club Admission Standards and Evaluation Rules" for the 2025-2026 season, Guangdong Hongyuan Club and Xinjiang Guanghui Club will be penalized with 6 points of admission deduction (corresponding to a reduction of RMB 600,000 in club league competition funds).

This letter is hereby issued. ”